BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23809746)

  • 1. [Biomarkers of cervical carcinogenesis associated with genital human papillomavirus infection].
    Oliveira A; Delgado C; Verdasca N; Pista A
    Acta Med Port; 2013; 26(2):139-44. PubMed ID: 23809746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic implication of high risk human papillomavirus E6 and E7 mRNA in patients with intraepithelial lesions of the cervix in relationship to age.
    Frega A; Lorenzon L; Giovagnoli MR; De Sanctis L; Fabiano V; Lukic A; Moscarini M; Torrisi MR; French D
    Int J Immunopathol Pharmacol; 2011; 24(2):461-70. PubMed ID: 21658320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.
    Schmitt M; Depuydt C; Benoy I; Bogers J; Antoine J; Arbyn M; Pawlita M;
    J Clin Microbiol; 2013 May; 51(5):1458-64. PubMed ID: 23447632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    Johansson H; Bjelkenkrantz K; Darlin L; Dilllner J; Forslund O
    PLoS One; 2015; 10(4):e0124460. PubMed ID: 25893988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions.
    Tsai HJ; Peng YW; Lin LY; Chou MC; Lee H; Chiou HL
    Cancer Detect Prev; 2005; 29(6):537-43. PubMed ID: 16289504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.
    Halfon P; Benmoura D; Agostini A; Khiri H; Martineau A; Penaranda G; Blanc B
    J Clin Virol; 2010 Feb; 47(2):177-81. PubMed ID: 20022804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
    Liu S; Minaguchi T; Lachkar B; Zhang S; Xu C; Tenjimbayashi Y; Shikama A; Tasaka N; Akiyama A; Sakurai M; Nakao S; Ochi H; Onuki M; Matsumoto K; Yoshikawa H; Satoh T
    PLoS One; 2018; 13(2):e0193061. PubMed ID: 29466435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
    Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the NucliSENS EasyQ HPV assay in the management of cervical intraepithelial neoplasia.
    Oliveira A; Verdasca N; Pista Â
    J Med Virol; 2013 Jul; 85(7):1235-41. PubMed ID: 23918542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L; Husaiyin S; Zhao F; Rezhake R; Niyazi M
    Clin Lab; 2018 Sep; 64(9):1363-1371. PubMed ID: 30274003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression.
    Chuery ACS; Silva IDCGD; Ribalta JCL; Speck NMG
    Braz J Infect Dis; 2017; 21(3):248-254. PubMed ID: 28347732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level.
    Berlin Grace VM; Niranjali Devaraj S; Radhakrishnan Pillai M; Devaraj H
    Gynecol Oncol; 2006 Oct; 103(1):113-9. PubMed ID: 16554086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.